Cargando…
Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease
We aimed to identify targets for neuropalliative care interventions in sporadic Creutzfeldt-Jakob disease by examining characteristics of patients and sources of distress and support among former caregivers. We identified caregivers of decedents with sporadic Creutzfeldt-Jakob disease from the Unive...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896185/ https://www.ncbi.nlm.nih.gov/pubmed/35239456 http://dx.doi.org/10.1080/19336896.2022.2043077 |
_version_ | 1784663101800448000 |
---|---|
author | Harrison, Krista L. Garrett, Sarah B. Gilissen, Joni Terranova, Michael J. Bernstein Sideman, Alissa Ritchie, Christine S. Geschwind, Michael D. |
author_facet | Harrison, Krista L. Garrett, Sarah B. Gilissen, Joni Terranova, Michael J. Bernstein Sideman, Alissa Ritchie, Christine S. Geschwind, Michael D. |
author_sort | Harrison, Krista L. |
collection | PubMed |
description | We aimed to identify targets for neuropalliative care interventions in sporadic Creutzfeldt-Jakob disease by examining characteristics of patients and sources of distress and support among former caregivers. We identified caregivers of decedents with sporadic Creutzfeldt-Jakob disease from the University of California San Francisco Rapidly Progressive Dementia research database. We purposively recruited 12 caregivers for in-depth interviews and extracted associated patient data. We analysed interviews using the constant comparison method and chart data using descriptive statistics. Patients had a median age of 70 (range: 60–86) years and disease duration of 14.5 months (range 4–41 months). Caregivers were interviewed a median of 22 (range 11–39) months after patient death and had a median age of 59 (range 45–73) years. Three major sources of distress included (1) the unique nature of sporadic Creutzfeldt-Jakob disease; (2) clinical care issues such as difficult diagnostic process, lack of expertise in sporadic Creutzfeldt-Jakob disease, gaps in clinical systems, and difficulties with end-of-life care; and (3) caregiving issues, including escalating responsibilities, intensifying stress, declining caregiver well-being, and care needs surpassing resources. Two sources of support were (1) clinical care, including guidance from providers about what to expect and supportive relationships; and (2) caregiving supports, including connection to persons with experience managing Creutzfeldt-Jakob disease, instrumental support, and social/emotional support. The challenges and supports described by caregivers align with neuropalliative approaches and can be used to develop interventions to address needs of persons with sporadic Creutzfeldt-Jakob disease and their caregivers. |
format | Online Article Text |
id | pubmed-8896185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-88961852022-03-05 Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease Harrison, Krista L. Garrett, Sarah B. Gilissen, Joni Terranova, Michael J. Bernstein Sideman, Alissa Ritchie, Christine S. Geschwind, Michael D. Prion Research Paper We aimed to identify targets for neuropalliative care interventions in sporadic Creutzfeldt-Jakob disease by examining characteristics of patients and sources of distress and support among former caregivers. We identified caregivers of decedents with sporadic Creutzfeldt-Jakob disease from the University of California San Francisco Rapidly Progressive Dementia research database. We purposively recruited 12 caregivers for in-depth interviews and extracted associated patient data. We analysed interviews using the constant comparison method and chart data using descriptive statistics. Patients had a median age of 70 (range: 60–86) years and disease duration of 14.5 months (range 4–41 months). Caregivers were interviewed a median of 22 (range 11–39) months after patient death and had a median age of 59 (range 45–73) years. Three major sources of distress included (1) the unique nature of sporadic Creutzfeldt-Jakob disease; (2) clinical care issues such as difficult diagnostic process, lack of expertise in sporadic Creutzfeldt-Jakob disease, gaps in clinical systems, and difficulties with end-of-life care; and (3) caregiving issues, including escalating responsibilities, intensifying stress, declining caregiver well-being, and care needs surpassing resources. Two sources of support were (1) clinical care, including guidance from providers about what to expect and supportive relationships; and (2) caregiving supports, including connection to persons with experience managing Creutzfeldt-Jakob disease, instrumental support, and social/emotional support. The challenges and supports described by caregivers align with neuropalliative approaches and can be used to develop interventions to address needs of persons with sporadic Creutzfeldt-Jakob disease and their caregivers. Taylor & Francis 2022-03-03 /pmc/articles/PMC8896185/ /pubmed/35239456 http://dx.doi.org/10.1080/19336896.2022.2043077 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Harrison, Krista L. Garrett, Sarah B. Gilissen, Joni Terranova, Michael J. Bernstein Sideman, Alissa Ritchie, Christine S. Geschwind, Michael D. Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease |
title | Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease |
title_full | Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease |
title_fullStr | Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease |
title_full_unstemmed | Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease |
title_short | Developing neuropalliative care for sporadic Creutzfeldt-Jakob Disease |
title_sort | developing neuropalliative care for sporadic creutzfeldt-jakob disease |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896185/ https://www.ncbi.nlm.nih.gov/pubmed/35239456 http://dx.doi.org/10.1080/19336896.2022.2043077 |
work_keys_str_mv | AT harrisonkristal developingneuropalliativecareforsporadiccreutzfeldtjakobdisease AT garrettsarahb developingneuropalliativecareforsporadiccreutzfeldtjakobdisease AT gilissenjoni developingneuropalliativecareforsporadiccreutzfeldtjakobdisease AT terranovamichaelj developingneuropalliativecareforsporadiccreutzfeldtjakobdisease AT bernsteinsidemanalissa developingneuropalliativecareforsporadiccreutzfeldtjakobdisease AT ritchiechristines developingneuropalliativecareforsporadiccreutzfeldtjakobdisease AT geschwindmichaeld developingneuropalliativecareforsporadiccreutzfeldtjakobdisease |